Towards personalized screening for hepatocellular carcinoma: Still not there

Autori: Calvaruso V.; Bruix J.
Anno di pubblicazione: 2020
Tipologia: Recensione in rivista
OA Link: http://hdl.handle.net/10447/509955

Abstract

In patients with HCV-related cirrhosis the annual risk of hepatocellular carcinoma (HCC) is 2–4%.1 However, with the advent of highly effective and well tolerated direct-acting antivirals...